PrEP4All sues federal government over 2025 HIV prevention research agreement Gay City News 4d Gay City News 4d Biotech Pharma All sources
Gilead Sciences, Inc. (GILD) is attracting investor attention: Here is what you should know Zacks 6d Zacks 6d Gilead Sciences Inc GILD Pharma
Earnings to watch: Gilead Sciences (GILD) reports Q1 results tomorrow Barchart 17h Barchart 17h GILD Pharma Biotechnology All sources
Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV Labiotech 14:07 Mon, 27 Apr Labiotech 14:07 Mon, 27 Apr Biotech Pharma
What's going on with arcus biosciences stock on Wednesday? Benzinga 20:23 Wed, 22 Apr Benzinga 20:23 Wed, 22 Apr Pharma Article paywall
Lenacapavir and the long road from ‘miracle’ to global access Observer Research Foundation 11:36 Thu, 16 Apr Observer Research Foundation 11:36 Thu, 16 Apr Pharma Biotech
California's highest court leans toward Gilead in considering drugmakers' 'duty to innovate' The Charlotte Observer 20:36
California's highest court to consider whether drugmakers have 'duty to innovate' The Charlotte Observer 11:26
Clio Health Champions: Jenny Yun, Senior Director, U.S. HIV Prevention Marketing – Gilead Sciences Muse by Clio 13:51 Tue, 05 May
Use of Gilead's HIV prevention shot rises, but US insurance gaps remain The Tribune, California 11:30 Tue, 05 May
Curious about Gilead (GILD) Q1 Performance? Explore Wall Street Estimates for Key Metrics Zacks 15:21 Mon, 04 May
The “Duty to Innovate” Arrives at the California Supreme Court: Oral Argument Set for May 6, 2026 Drug & Device Law 10:03 Mon, 04 May
PrEP4All sues federal government over 2025 HIV prevention research agreement Gay City News 17:42 Sat, 02 May